Raymond James Financial Services Advisors Inc. grew its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 3.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 22,159 shares of the medical equipment provider’s stock after purchasing an additional 823 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Zimmer Biomet Holdings were worth $2,845,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Zimmer Biomet Holdings by 4.1% in the 2nd quarter. BlackRock Inc. now owns 17,419,463 shares of the medical equipment provider’s stock valued at $2,236,657,000 after purchasing an additional 679,080 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Zimmer Biomet Holdings by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 13,380,517 shares of the medical equipment provider’s stock valued at $1,718,057,000 after purchasing an additional 339,106 shares during the last quarter. State Street Corp boosted its stake in shares of Zimmer Biomet Holdings by 2.4% in the 1st quarter. State Street Corp now owns 8,193,165 shares of the medical equipment provider’s stock valued at $1,000,463,000 after purchasing an additional 191,747 shares during the last quarter. Longview Partners Guernsey LTD boosted its stake in shares of Zimmer Biomet Holdings by 4.4% in the 2nd quarter. Longview Partners Guernsey LTD now owns 6,377,711 shares of the medical equipment provider’s stock valued at $818,898,000 after purchasing an additional 269,184 shares during the last quarter. Finally, Northern Trust Corp boosted its stake in shares of Zimmer Biomet Holdings by 20.2% in the 2nd quarter. Northern Trust Corp now owns 4,010,274 shares of the medical equipment provider’s stock valued at $514,919,000 after purchasing an additional 673,079 shares during the last quarter. 85.22% of the stock is currently owned by institutional investors.

WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/raymond-james-financial-services-advisors-inc-acquires-823-shares-of-zimmer-biomet-holdings-inc-zbh/1636528.html.

Several research analysts have recently issued reports on the stock. Stifel Nicolaus reaffirmed a “hold” rating and issued a $125.00 target price on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Gabelli assumed coverage on shares of Zimmer Biomet Holdings in a research note on Thursday, August 24th. They issued a “buy” rating and a $142.00 target price on the stock. Zacks Investment Research lowered shares of Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 8th. SunTrust Banks, Inc. reaffirmed a “buy” rating and issued a $136.00 target price on shares of Zimmer Biomet Holdings in a research note on Monday, October 2nd. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 target price on shares of Zimmer Biomet Holdings in a research note on Tuesday, July 11th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $136.55.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) opened at 119.51 on Tuesday. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49. The firm has a 50-day moving average of $116.07 and a 200-day moving average of $120.38. The company has a market cap of $24.16 billion, a price-to-earnings ratio of 34.04 and a beta of 1.19.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.10 by ($0.02). The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. Zimmer Biomet Holdings’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.02 earnings per share. Equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.23 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be issued a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date is Thursday, September 21st. Zimmer Biomet Holdings’s payout ratio is 27.59%.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of the stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.07% of the stock is currently owned by corporate insiders.

Zimmer Biomet Holdings Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.